{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:11:12Z","timestamp":1648876272039},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1002\/jps.22717","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T21:01:33Z","timestamp":1313096493000},"page":"5299-5307","source":"Crossref","is-referenced-by-count":2,"title":["Ocular Hypotensive Action of a Novel Tetrahydroquinoline Analog in Rabbit: Physicochemical Evaluation"],"prefix":"10.1016","volume":"100","author":[{"given":"Chandrasena R.","family":"Pamulapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald D.","family":"Schoenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22717_bb0010","series-title":"Manual of ocular diagnosis and therapy","first-page":"259","article-title":"Glaucoma","author":"Pavan\u2010Langston","year":"2008"},{"key":"10.1002\/jps.22717_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMra0804630","article-title":"Primary open\u2010angle glaucoma","volume":"360","author":"Kwon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.22717_bb0020","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archopht.1995.01100070092031","article-title":"Risk factors for open\u2010angle glaucoma","volume":"113","author":"Leske","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.22717_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9394(14)76171-9","article-title":"Glaucomatous optic neuropathy","volume":"113","author":"Van Buskirk","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.22717_bb0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","article-title":"Glaucoma and its treatment: A review","volume":"62","author":"Lee","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1002\/jps.22717_bb0035","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM199810293391808","article-title":"Medical management of glaucoma","volume":"339","author":"Alward","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.22717_bb0040","first-page":"3035","article-title":"Topical application of serotonin or the 5\u2010HT1 agonist 5\u2010CT on intraocular pressure in rabbits","volume":"34","author":"Meyer\u2010Bothling","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.22717_bb0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jop.1987.3.279","article-title":"Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in the rabbit","volume":"3","author":"Krootila","year":"1987","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22717_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00053437","article-title":"Effect of ketanserin on intraocular pressure","volume":"4","author":"Costagliola","year":"1990","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1002\/jps.22717_bb0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.77.6.344","article-title":"Effect of topical ketanserin administration on intraocular pressure","volume":"77","author":"Costagliola","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1002\/jps.22717_bb0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0014-4835(91)90050-O","article-title":"Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients","volume":"52","author":"Costagliola","year":"1991","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.22717_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/exer.1993.1116","article-title":"The presence of serotonin (5\u2010HT1) receptors negatively coupled to adenylate cyclase in rabbit and human iris\u2013ciliary processes","volume":"57","author":"Barnett","year":"1993","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.22717_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/02713688709025209","article-title":"Characterization of serotonin receptors in the iris\u2013ciliary body of the albino rabbit","volume":"6","author":"Mallorga","year":"1987","journal-title":"Curr Eye Res"},{"key":"10.1002\/jps.22717_bb0075","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0006-2952(91)90294-F","article-title":"Regulation of 5\u2010HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist","volume":"42","author":"Michael","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/jps.22717_bb0080","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1523\/JNEUROSCI.08-10-03713.1988","article-title":"Evidence for the presence of serotonergic nerves and receptors in the iris\u2013ciliary body complex of the rabbit","volume":"8","author":"Tobin","year":"1988","journal-title":"J Neurosci"},{"key":"10.1002\/jps.22717_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000310730","article-title":"Do \u03b2\u2010adreno receptors and serotonin 5\u2010HT1A receptors have similar functions in the control of intraocular pressure in the rabbit?","volume":"210","author":"Osborne","year":"1996","journal-title":"Ophthalmologica"},{"key":"10.1002\/jps.22717_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/exer.1999.0756","article-title":"The 5\u2010HT1A receptor agonist 8\u2010OH\u2010DPAT lowers intraocular pressure in normotensive NZW rabbits","volume":"69","author":"Chidlow","year":"1999","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.22717_bb0095","first-page":"S836","article-title":"Serotonergic and endothelin (ET)\u20101 effects on aqueous humor dynamics in monkeys","volume":"37","author":"Millar","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.22717_bb0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1076\/ceyr.16.8.769.8988","article-title":"Effect of 5\u2010methyl urapidil, an alpha 1A\u2010adrenergic antagonist and 5\u2010hydroxytryptamine 1A agonist, on aqueous humor dynamics in monkeys and rabbits","volume":"16","author":"Wang","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1002\/jps.22717_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.1985.1.137","article-title":"Mechanism of the ocular hypotensive action of ketanserin","volume":"1","author":"Chang","year":"1985","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22717_bb0110","first-page":"S734","article-title":"The effect of Anplag\u00ae (sarpogrelate HCl), novel selective 5\u2010HT2 antagonist on intraocular pressure in glaucoma patients","volume":"36","author":"Takenaka","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.22717_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1124\/jpet.103.049528","article-title":"Evaluation of the ocular hypotensive response of serotonin 5\u2010HT1A and 5\u2010HT2 receptor ligands in conscious ocular hypertensive cynomolgous monkeys","volume":"306","author":"May","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22717_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exer.1999.0694","article-title":"8\u2010OH\u2010DPAT\u2010induced ocular hypertension: Sites and mechanisms of action","volume":"69","author":"Chu","year":"1999","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.22717_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/eye.2000.131","article-title":"5\u2010Hydroxytryptamine 1A agonists: Potential use in glaucoma. Evidence from animal studies","volume":"14","author":"Osborne","year":"2000","journal-title":"Eye"},{"key":"10.1002\/jps.22717_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/jop.1992.8.11","article-title":"Ocular hypotensive actions of serotonin antagonist\u2013ketanserin analogs","volume":"8","author":"Chiou","year":"1992","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22717_bb0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000310143","article-title":"Double\u2010blind study in the treatment of normal tension glaucoma with naftidrofuryl","volume":"201","author":"Mermoud","year":"1990","journal-title":"Ophthalmologica"},{"key":"10.1002\/jps.22717_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157015908787386104","article-title":"Selective seotonin reuptake inhibitors: A review of its effects on intraocular pressure","volume":"6","author":"Costagliola","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1002\/jps.22717_bb0145","series-title":"The development of compounds acting on serotonin receptors as antiglaucoma agents and their ocular penetration","author":"Gadiraju","year":"1997"},{"key":"10.1002\/jps.22717_bb0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00003088-199120040-00002","article-title":"Clinical pharmacokinetics of ketanserin","volume":"20","author":"Persson","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.22717_bb0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0939-6411(97)00055-6","article-title":"Serotonin antagonists for use as antiglaucoma agents and their ocular penetration","volume":"43","author":"Schoenwald","year":"1997","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22717_bb0160","article-title":"Tetrahydroquinoline analogues for use in glaucoma treatment","author":"Schoenwald","year":"1998","journal-title":"Patent"},{"key":"10.1002\/jps.22717_bb0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000265135","article-title":"Effect of timolol on aqueous humor dynamics in the rabbit","volume":"13","author":"Vareilles","year":"1981","journal-title":"Ophthalmic Res"},{"key":"10.1002\/jps.22717_bb0170","series-title":"Strategy of drug design. A molecular guide to biological activity","article-title":"Appendix I","author":"Hansch","year":"1973"},{"key":"10.1002\/jps.22717_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","article-title":"Ocular drug delivery. Pharmacokinetic considerations","volume":"18","author":"Schoenwald","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.22717_bb0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: Recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22717_bb0185","article-title":"Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: Absorption, disposition and non\u2010compartmental analysis","author":"Pamulapati","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22717_bb0190","article-title":"Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: Compartmental analysis and PK\/PD evaluation","author":"Pamulapati","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22717_bb0195","series-title":"pKa prediction for organic acids and bases","author":"Perrin","year":"1981"},{"key":"10.1002\/jps.22717_bb0200","series-title":"The determination of ionization constants: A laboratory manual","author":"Albert","year":"1971"},{"key":"10.1002\/jps.22717_bb0205","series-title":"Remington's pharmacutical sciences","first-page":"1506","article-title":"Ophthalmic preparations","author":"Deardorff","year":"1980"},{"key":"10.1002\/jps.22717_bb0210","series-title":"Havener`s ocular pharmacology","first-page":"22","article-title":"Pharmacokinetics","author":"DeSantis","year":"1994"},{"key":"10.1002\/jps.22717_bb0215","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.2600670614","article-title":"Relationship between steroid permeability across excised rabbit cornea and octanal\u2013water partition coefficient","volume":"67","author":"Schoenwald","year":"1978","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22717_bb0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.1988.4.137","article-title":"Influence of corneal epithelial integrity on the penetration of timolol prodrugs","volume":"4","author":"Chien","year":"1988","journal-title":"J Ocul Pharmacol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T20:50:50Z","timestamp":1560459050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915318219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0022354915318219"],"URL":"https:\/\/doi.org\/10.1002\/jps.22717","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}